| scholarly article | Q13442814 |
| P2093 | author name string | P L De Jager | |
| H Weiner | |||
| T Chitnis | |||
| R Bakshi | |||
| K K Miller | |||
| B C Healy | |||
| B I Glanz | |||
| K Raghavan | |||
| A Musallam | |||
| R Bove | |||
| P2860 | cites work | The neuroendocrine axis in patients with multiple sclerosis | Q48691841 |
| A critical evaluation of simple methods for the estimation of free testosterone in serum | Q49081910 | ||
| Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. | Q51000363 | ||
| Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness. | Q51953967 | ||
| Regional hippocampal atrophy in multiple sclerosis. | Q51960814 | ||
| Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. | Q55039401 | ||
| Association of hypogonadism with vitamin D status: the European Male Ageing Study | Q60721232 | ||
| High prevalence of androgen deficiency and abnormal lipid profile in infertile men with non-obstructive azoospermia | Q83942958 | ||
| Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study | Q84783724 | ||
| Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 | ||
| Body size and risk of MS in two cohorts of US women | Q22241653 | ||
| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
| Testosterone, body composition and aging | Q33708584 | ||
| Diagnosis and treatment of hypogonadism in men. | Q33844232 | ||
| Neuroendocrine aging in men. Andropause and somatopause | Q34380984 | ||
| Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis | Q34573482 | ||
| Estrogen and testosterone therapies in multiple sclerosis | Q34610594 | ||
| Testosterone treatment in multiple sclerosis: a pilot study | Q34628272 | ||
| Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts | Q35137175 | ||
| Sex hormones modulate brain damage in multiple sclerosis: MRI evidence | Q35485697 | ||
| Prevention and treatment of MS: studying the effects of vitamin D. | Q35956133 | ||
| A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study | Q36617521 | ||
| Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone | Q36841506 | ||
| Association between plasma 25-OH vitamin D and testosterone levels in men | Q37015875 | ||
| Autoimmune diseases and reproductive aging | Q37248985 | ||
| Leptin as a metabolic link to multiple sclerosis | Q37770406 | ||
| Testosterone levels and cognition in elderly men: a review. | Q37893290 | ||
| Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. | Q37901645 | ||
| The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. | Q38045613 | ||
| High rates of physician services utilization at least five years before multiple sclerosis diagnosis | Q38069515 | ||
| Sexual disparities in the incidence and course of MS. | Q38100894 | ||
| Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. | Q39857907 | ||
| Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. | Q42882342 | ||
| Adult testosterone and calculated free testosterone reference ranges by tandem mass spectrometry | Q44671989 | ||
| American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. | Q44983422 | ||
| Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis | Q46191626 | ||
| Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up | Q48181379 | ||
| Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. | Q48612350 | ||
| P433 | issue | 12 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| disability | Q12131 | ||
| testosterone | Q1318776 | ||
| testosterone | Q27863114 | ||
| P304 | page(s) | 1584-1592 | |
| P577 | publication date | 2014-04-07 | |
| P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
| P1476 | title | Low testosterone is associated with disability in men with multiple sclerosis | |
| P478 | volume | 20 |
| Q90443738 | A case for gender-based approach to multiple sclerosis therapeutics |
| Q92390017 | Androgen deprivation therapy increases brain ageing |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q47590435 | Associations between clinically diagnosed testicular hypofunction and systemic lupus erythematosus: a record linkage study |
| Q47740112 | Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients |
| Q40921876 | Gender identity disorders and multiple sclerosis risk: A national record-linkage study |
| Q38616570 | Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis |
| Q51129390 | High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. |
| Q47747865 | Hormones and MS: Risk factors, biomarkers, and therapeutic targets |
| Q45071979 | Increased risk of erectile dysfunction in men with multiple sclerosis: an Italian cross-sectional study |
| Q90605447 | It is time to conduct phase 3 clinical trials of sex hormones in MS - Yes |
| Q94562658 | Kinetics of T cell response in the testes and CNS during experimental autoimmune encephalomyelitis: Simultaneous blood-brain and -testis barrier permeability? |
| Q47598299 | Male factor infertility and risk of multiple sclerosis: A register-based cohort study |
| Q38685411 | Multiple sclerosis in men: management considerations. |
| Q58737028 | Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches |
| Q39063431 | Optic neuritis secondary to antiandrogen therapy |
| Q57166770 | Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children |
| Q93147213 | Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis |
| Q36065033 | Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment |
| Q39168246 | Single-nucleotide polymorphism rs948854 in human galanin gene and multiple sclerosis: a gender-specific risk factor |
| Q36166984 | The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS. |
| Q38783057 | The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future. |
| Q92833943 | The effect of sex on multiple sclerosis risk and disease progression |
| Q39015338 | The importance of studying sex differences in disease: The example of multiple sclerosis |
| Q102060892 | The role of sex hormones in women with Multiple Sclerosis: from puberty to assisted reproductive techniques |
| Q47201174 | The role of testosterone in MS risk and course |
| Q37534278 | Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin |
Search more.